RVMD - Revolution Medicines, Inc.
99.64
-1.550 -1.556%
Share volume: 1,704,583
Last Updated: 03-05-2026
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
-0.04%
PREVIOUS CLOSE
CHG
CHG%
$101.19
-1.55
-0.02%
Summary score
14%
Profitability
0%
Dept financing
15%
Liquidity
43%
Performance
20%
Sector
Manufacturing
Industry
Pharmaceutical Products/Biological Products, Except Diagnostic Substances
Long-term ratios 31-Dec-2014 - 31-Dec-2018
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-14.34%
Return on assets
-6.5%
Return on sales
0%
Return on invested capital
-24.09%
Total debt ratio
44.29%
Debt ratio change over timeo
0%
Current Ratio
2.8%
Quick Ratio
0%
Cash Position Ratio
2.28%
Short-term ratios 31-Dec-2017 - 31-Dec-2018
The data are presented for the financials results of the quarters of the last year.
Return on equity
-14.34%
Return on assets
-6.5%
Return on sales
0%
Return on invested capital
-24.09%
Total debt ratio
44.29%
Debt ratio change over timeo
0%
Current Ratio
2.8%
Quick Ratio
0%
Cash Position Ratio
2.28%
Last quarter ratios 31-Dec-2018
The data are presented for the financials results of the last quarter.
Return on equity
-14.34%
Return on assets
-6.5%
Return on sales
0%
Return on invested capital
-24.09%
Total debt ratio
44.29%
Debt ratio change over time
0%
Current Ratio
2.8%
Quick Ratio
0%
Cash Position Ratio
2.28%
Performance ratios (change over 4 years) 31-Dec-2014 - 31-Dec-2018
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
0%
Return on assets
0%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
0%
Debt ratio change over time
0%
Current Ratio
0%
Quick Ratio
0%
Cash Position Ratio
0%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | RVMD | AMGN | GILD | BIIB |
|---|---|---|---|---|
| Return on equity | -14.34% | 7.28% | 9.32% | 7.23% |
| Return on assets | -6.5% | 3.37% | 5.52% | 5.41% |
| Return on sales | 0% | 43.45% | 49.58% | 43.11% |
| Return on invested capital | -24.09% | 7.6% | 8.14% | 7.34% |
| Profitability | 0% | 80% | 100% | 88% |
| Total debt ratio | 44.29% | 67.42% | 66.51% | 46.84% |
| Debt ratio change over time | 0% | 0% | 3.92% | 4.65% |
| Dept financing | 16% | 25% | 46% | 42% |
| Current Ratio | 2.8% | 3.29% | 3.17% | 2.66% |
| Quick Ratio | 0% | 3.03% | 3.09% | 2.38% |
| Cash Position Ratio | 2.28% | 0.83% | 2.59% | 1.34% |
| Liquididy | 41% | 55% | 51% | 37% |
| Short-term ratios | RVMD | AMGN | GILD | BIIB |
|---|---|---|---|---|
| Return on equity | -14.34% | 14.64% | 6.26% | 8.29% |
| Return on assets | -6.5% | 3.79% | 3.16% | 5.94% |
| Return on sales | 0% | 43.56% | 37.32% | 44.68% |
| Return on invested capital | -24.09% | 11.94% | 6.39% | 8.23% |
| Profitability | 0% | 90% | 58% | 81% |
| Total debt ratio | 44.29% | 78.97% | 66.55% | 47.35% |
| Debt ratio change over time | 0% | 0% | 3.92% | 4.65% |
| Dept financing | 14% | 25% | 42% | 40% |
| Current Ratio | 2.8% | 3.29% | 3.17% | 2.66% |
| Quick Ratio | 0% | 3.03% | 3.09% | 2.38% |
| Cash Position Ratio | 2.28% | 0.83% | 2.59% | 1.34% |
| Liquididy | 43% | 58% | 74% | 52% |